MEDICINOVA, INC. Income (Loss) from Continuing Operations before Income Taxes, Domestic
MEDICINOVA, INC. (MNOV) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$12.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-03-10
- MEDICINOVA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$12.00M.
- MEDICINOVA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$11.06M.
- MEDICINOVA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$8.59M.
- MEDICINOVA, INC. income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$14.08M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$12.00M 10-K · filed 2026-03-10 |
| 2024-12-31 | -$11.06M 10-K · filed 2026-03-10 |
| 2023-12-31 | -$8.59M 10-K · filed 2025-02-19 |
| 2022-12-31 | -$14.08M 10-K · filed 2024-02-15 |
| 2021-12-31 | -$10.15M 10-K/A · filed 2023-03-28 |
| 2020-12-31 | -$13.87M 10-K · filed 2022-02-16 |
| 2019-12-31 | -$12.95M 10-K · filed 2021-02-19 |
| 2018-12-31 | -$14.69M 10-K · filed 2020-02-13 |
| 2017-12-31 | -$12.94M 10-K · filed 2019-02-13 |
| 2016-12-31 | -$10.89M 10-K · filed 2019-02-13 |
| 2015-12-31 | -$8.87M 10-K · filed 2018-02-13 |
| 2014-12-31 | -$9.23M 10-K · filed 2017-02-14 |
| 2013-12-31 | -$4.05M 10-K · filed 2015-03-12 |
| 2012-12-31 | -$10.99M 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |